AP
MDT icon

Archon Partners’s Medtronic MDT Stock Holding History

Archon Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-101,300
Closed -$9.12M – 41
2024
Q3 		$9.12M Sell
101,300
-9,700
-9% -$816K 1.05% 32
2024
Q2 		$8.74M Hold
111,000
– – 1.12% 30
2024
Q1 		$9.67M Buy
111,000
+2,000
+2% +$171K 1.18% 31
2023
Q4 		$8.98M Buy
+109,000
New +$8.31M 1.24% 31

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Archon Partners's MDT Position: Q4 2024 in Review

Archon Partners sold out of Medtronic (MDT) in Q4 2024, closing a stake of 101,300 shares — an estimated $9.12M sold.

Archon Partners first reported a position in MDT in Q4 2023 and held it in 4 quarters. The position peaked at $9.67M in Q1 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Archon Partners reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Archon Partners sold 101,300 Medtronic shares in Q4 2024, an estimated $9.12M.
  • Archon Partners first reported a position in Medtronic in Q4 2023 and held it in 4 quarters.
  • Archon Partners's Medtronic position peaked at $9.67M in Q1 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Archon Partners's 13F filing for Q4 2024, filed 14 Feb 2025.